Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box

Published 23/11/2022, 13:58
Updated 23/11/2022, 15:10
© Reuters. Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box

Benzinga -

  • Barclays (LON:BARC) raised the price target on Burlington Stores, Inc. (NYSE: BURL) from $164 to $230. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Burlington shares fell 0.1% to $189.87 in pre-market trading.
  • Wedbush cut the price target for Jack in the Box Inc. (NASDAQ: JACK) from $115 to $100. Wedbush analyst Nick Setyan maintained an Outperform rating on the stock. Jack in the Box shares fell 16.1% to close at $71.24 on Tuesday.
  • Barclays cut the price target on Arvinas, Inc. (NASDAQ: ARVN) from $90 to $70. Arvinas shares fell 5.5% to close at $40.70 on Tuesday.
  • Bernstein boosted the price target for Analog Devices (NASDAQ:ADI), Inc. (NASDAQ: ADI) from $190 to $200. Analog Devices shares gained 0.9% to $169.98 in pre-market trading.
  • Piper Sandler slashed the price target for Teva Pharmaceutical Industries (NYSE:TEVA) Limited (NYSE: TEVA) from $8 to $7. Teva Pharmaceutical shares fell 0.7% to $8.91 in pre-market trading.
  • Citigroup (NYSE:C) cut the price target on MacroGenics, Inc. (NASDAQ: MGNX) from $16 to $7. MacroGenics shares gained 2.7% to $6.35 in pre-market trading.
  • Wells Fargo (NYSE:WFC) boosted the price target on Zimmer Biomet Holdings, Inc. (NYSE: ZBH) from $116 to $124. Zimmer Biomet shares rose 1.6% to $117.22 in pre-market trading.

Don’t forget to check out our premarket coverage here .

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.